Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Tables)

v3.21.1
Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Schedule of Marketable Securities

Marketable Securities: Valued using quoted prices in active markets for identical assets.

 

   

Quoted Prices in

Active
Markets for Identical Assets
or Liabilities
(Level 1)

     Quoted Prices for
Similar Assets or
Liabilities in Active
Markets
(Level 2)		     Significant
Unobservable
Inputs
(Level 3)		  
Marketable securities at March 31, 2021   $ 30,480,537     $          -     $              -  
                         
Marketable securities at December 31, 2020   $ 16,718,452     $ -     $ -  
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share

The following securities are excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:

 

    For the Three Months Ended
March 31,		  
    2021     2020  
Stock Options     -       20  
RSUs     394,680       -  
Warrants to purchase common stock     5,463,032       123,645  
Pre-funded Warrants to purchase common stock     986,486       15,000  
Series D Preferred Convertible Stock     36,496       105,677  
Warrants to purchase Series C Preferred stock     27,500       995,000  
Total potentially dilutive shares     6,908,194       1,239,342